Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
Neurology|December 13, 2016
Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLBAlan J Thomas, Johannes Attems, Sean J Colloby, et al.Age and Ageing|July 20, 2025
Detecting delirium in Parkinson's disease: an evaluation of diagnostic accuracy of bedside toolsRachael Ashleigh Lawson, Sarah Joanna Richardson, Florence Gerakios, et al.Molecular Neurodegeneration|January 23, 2019
Dementia with Lewy bodies: an update and outlookTiago Fleming Outeiro, David J Koss, Daniel Erskine, et al.Neuroscience Letters|April 17, 2003
Patients with a novel neurofilamentopathy: dementia with neurofilament inclusionsNigel J Cairns, Robert H Perry, Evelyn Jaros, et al.Clinical Neuropharmacology|January 18, 2014
Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized studyMurat Emre, Werner Poewe, Peter Paul De Deyn, et al.International Journal of Geriatric Psychiatry|April 18, 2019
Inflammation in mild cognitive impairment due to Parkinson's disease, Lewy body disease, and Alzheimer's diseaseEleanor King, John O'Brien, Paul Donaghy, et al.Journal of Neurology|April 27, 2018
Longitudinal diffusion tensor imaging changes in early Parkinson's disease: ICICLE-PD studyThais Minett, Li Su, Elijah Mak, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2015
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseDaniel Weintraub, Tanya Simuni, Chelsea Caspell-Garcia, et al.Plos One|August 21, 2018
Cognition among individuals along a spectrum of increased risk for Parkinson's diseaseLana M Chahine, Liz Urbe, Chelsea Caspell-Garcia, et al.The Lancet. Neurology|December 25, 2003
Dementia with Lewy bodiesIan McKeith, Jacobo Mintzer, Dag Aarsland, et al.Pageof 8